摘要
To the Editor： Hydroxychloroquine （HCQ） is commonly used in systemic lupus erythematosus （SLE）, rheumatoid arthritis, and other autoimmune disorders. We report a case of psoriasis-form erythroderma induced by HCQ in an SLE patient. Thus, rheumatologists and dermatologists should be aware of the possibility of HCQ-induced psoriasis-form lesions.
To the Editor： Hydroxychloroquine （HCQ） is commonly used in systemic lupus erythematosus （SLE）, rheumatoid arthritis, and other autoimmune disorders. We report a case of psoriasis-form erythroderma induced by HCQ in an SLE patient. Thus, rheumatologists and dermatologists should be aware of the possibility of HCQ-induced psoriasis-form lesions.
作者
Wen-Ming Wang
Kevin Yu Wang
Tao Wang
Hong-Zhong Jin
Kai Fang
Wen-Ming Wang;Kevin Yu Wang;Tao Wang;Hong-Zhong Jin;Kai Fang(Department of Dermatology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730 China;State University of New York Upstate Medical University,Syracuse,NY 13210,USA)
